hydrogen sulfide has been researched along with Hypertension in 119 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperhomocysteinemia, an increased level of plasma homocysteine, is an independent risk factor for the development of premature arterial fibrosis with peripheral and cerebro-vascular, neurogenic and hypertensive heart disease, coronary occlusion and myocardial infarction, as well as venous thromboembolism." | 8.86 | Homocysteine to hydrogen sulfide or hypertension. ( Mishra, PK; Sen, U; Tyagi, N; Tyagi, SC, 2010) |
| "Nitric oxide (NO) and hydrogen sulfide (H2S) pathways are involved in the development of hypertension, a condition that can originate from early life." | 7.83 | Maternal N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and prevents programmed hypertension in male offspring exposed to prenatal dexamethasone and postnatal high-fat diet. ( Chen, CC; Huang, LT; Lin, YJ; Sheen, JM; Tai, IH; Tain, YL; Tiao, MM; Yu, HR, 2016) |
| "Objective was to investigate the effects of Tai Chi exercise on nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S) levels, and blood pressure (BP) in patients with essential hypertension (EH)." | 7.81 | Effects of Tai Chi exercise on blood pressure and plasma levels of nitric oxide, carbon monoxide and hydrogen sulfide in real-world patients with essential hypertension. ( Pan, X; Tao, S; Zhang, Y, 2015) |
| "Endogenous hydrogen sulfide (H(2)S) plays an important role in hypertension." | 7.77 | Erythrocytic or serum hydrogen sulfide association with hypertension development in untreated essential hypertension. ( Geng, B; Shi, XQ; Sun, NL; Tang, CS; Zeng, Q; Zhao, J; Zheng, M, 2011) |
| "To investigate the effects of hydrogen sulfide (H2S) on vascular inflammation and blood pressure in spontaneously hypertensive rats (SHR)." | 7.74 | [Hypotensive effects of hydrogen sulfide via attenuating vascular inflammation in spontaneously hypertensive rats]. ( DU, JB; Jin, HF; Liang, JM; Sun, Y; Tang, CS, 2008) |
| "To explore the significance of hydrogen sulfide/cystathionine gamma-lyase (H(2)S/CSE) system in the development of hypertension and the effects of H(2)S/CSE system on the modulation of aortic remodeling process of hypertension." | 7.72 | [Changes and significance of hydrogen sulfide/cystathionine gamma-lyase system in hypertension: an experimental study with rats]. ( Du, JB; Tang, CS; Yan, H, 2004) |
| "Hydrogen sulfide (H2S) is a gaseous signalling molecule with antihypertensive properties." | 6.53 | Hydrogen sulfide in hypertension. ( Hillebrands, JL; Joles, JA; van den Born, JC; van Goor, H, 2016) |
| "Hydrogen sulfide (H2 S) has traditionally been viewed as a highly toxic gas; however, recent studies have implicated H2 S as a third member of the gasotransmitter family, exhibiting properties similar to NO and carbon monoxide." | 6.52 | Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. ( Ferro, A; Ji, Y; Ma, Y; Meng, G; Xie, L, 2015) |
| "The metabolic syndrome is a group of abnormalities including obesity, high blood pressure, hyperinsulinemia, high blood glucose levels and hyperlipidemia that together greatly increase the risk of developing cardiovascular disease and Type 2 diabetes." | 6.47 | Hydrogen sulfide and the metabolic syndrome. ( Chang, T; Desai, KM; Untereiner, A; Wu, L, 2011) |
| "Hypertension is a major risk factor for intimal hyperplasia (IH) and re-stenosis following vascular and endovascular interventions." | 5.72 | Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis. ( Allagnat, F; Corpataux, JM; Déglise, S; Deslarzes-Dubuis, C; Lambelet, M; Longchamp, A; Macabrey, D; Ozaki, CK, 2022) |
| "In newborns born to mothers with preeclampsia, an increase in the concentration of hydrogen sulfide was detected in the blood, which is probably a compensatory reaction aimed at restoring vascular homeostasis during early postnatal adaptation." | 5.62 | Hydrogen sulfide content in pregnant women with preeclampsia in late gestation and their newborns. ( Baev, TO; Kharlamova, NV; Klycheva, MM; Kuzmenko, GN; Nazarov, SB; Panova, IA; Popova, IG; Sadov, RI; Sitnikova, OG; Veselkova, YN, 2021) |
| "NaHS treatment decreased hypertension-induced Cx40/Cx43 expressions in T lymphocytes from SHR." | 5.48 | Hydrogen Sulfide Attenuates Hypertensive Inflammation via Regulating Connexin Expression in Spontaneously Hypertensive Rats. ( Li, L; Li, XZ; Ma, KT; Ni, X; Peng, M; Shan, LY; Shen, TW; Si, JQ; Yu, XS; Zhang, L, 2018) |
| "Suramin treatment exerted negligible effect on the RAS pathway in the adult male offspring kidneys." | 5.43 | N-Acetylcysteine Prevents Programmed Hypertension in Male Rat Offspring Born to Suramin-Treated Mothers. ( Hsu, CN; Lee, CT; Lin, YJ; Tain, YL; Tsai, CC, 2016) |
| "Hypertension is a risk factor for the cardiovascular diseases." | 5.42 | Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension. ( Akcali, KC; Ayaloglu-Butun, F; Demirel-Yilmaz, E; Han, S; Uludag, MO; Usanmaz, SE, 2015) |
| " H2S therapy can also restore eNOS function and NO bioavailability and attenuate the pathological changes in the liver in L-NAME-induced hypertensive rats." | 5.40 | Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway. ( Dai, J; Duan, X; Ji, W; Jiang, X; Liu, S; Wu, Y; Yang, T, 2014) |
| "Hydrogen sulfide is a vasorelaxant and proangiogenic gas with therapeutic potential in several diseases." | 5.40 | Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. ( Burke, SD; Faas, MM; Holwerda, KM; Jaffe, IZ; Kang, PM; Karumanchi, SA; Lely, AT; McCurley, A; Stillman, IE; van Goor, H; Zsengeller, Z, 2014) |
| "The exact etiology of preeclampsia is unknown, but there is growing evidence of an imbalance in angiogenic growth factors and abnormal placentation." | 5.39 | Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. ( Ahmad, S; Ahmed, A; Baily, J; Buhimschi, CS; Buhimschi, IA; Cai, M; Crispi, F; Cudmore, M; Fujisawa, T; Gratacós, E; Hadoke, PW; Miller, MR; Rennie, J; Wang, K; Wang, R, 2013) |
| "Hydrogen sulfide (H(2)S) is a poisonous gas which can be lethal." | 5.37 | Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: how harmful is it? ( Capasso, R; De Santo, NG; Ingrosso, D; Lanza, D; Perna, AF; Raiola, I; Sepe, I, 2011) |
| "Hydrogen sulfide (H(2)S) is a newly found modulator in vascular system." | 5.32 | The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. ( Du, J; Tang, C; Yan, H, 2004) |
| "Hyperhomocysteinemia, an increased level of plasma homocysteine, is an independent risk factor for the development of premature arterial fibrosis with peripheral and cerebro-vascular, neurogenic and hypertensive heart disease, coronary occlusion and myocardial infarction, as well as venous thromboembolism." | 4.86 | Homocysteine to hydrogen sulfide or hypertension. ( Mishra, PK; Sen, U; Tyagi, N; Tyagi, SC, 2010) |
| "To elucidate whether by inhibiting inflammasome and oxidative stress, hydrogen sulfide (H2S) can ameliorate endothelial dysfunction with hypertension." | 3.91 | Hydrogen sulfide improves endothelial dysfunction by inhibiting the vicious cycle of NLRP3 inflammasome and oxidative stress in spontaneously hypertensive rats. ( Dong, J; Guo, Q; Jin, S; Li, J; Teng, X; Tian, D; Wu, Y, 2019) |
| "The repeated iv saline injection induced a slight hypertension accompanied by disturbances in anaerobic cysteine metabolism in the rat liver." | 3.85 | The effect of NaCl on the level of reduced sulfur compounds in rat liver. Implications for blood pressure increase. ( Bednarski, M; Bilska-Wilkosz, A; Górny, M; Iciek, M; Knutelska, J; Kotańska, M; Kowalczyk-Pachel, D; Sokołowska-Jeżewicz, M; Zygmunt, M, 2017) |
| "Nitric oxide (NO) and hydrogen sulfide (H2S) pathways are involved in the development of hypertension, a condition that can originate from early life." | 3.83 | Maternal N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and prevents programmed hypertension in male offspring exposed to prenatal dexamethasone and postnatal high-fat diet. ( Chen, CC; Huang, LT; Lin, YJ; Sheen, JM; Tai, IH; Tain, YL; Tiao, MM; Yu, HR, 2016) |
| "Our results indicated that antioxidant therapy, by melatonin or N-acetylcysteine, in pregnant rats with nitric oxide deficiency can prevent programmed hypertension in male adult offspring." | 3.83 | Maternal melatonin or N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and renal transcriptome to prevent prenatal N ( Chan, JY; Hsu, CN; Lee, CT; Tain, YL, 2016) |
| "To evaluate the effect of using antihypertensive classes of drugs of the calcium channel antagonists and inhibitors of angiotensin-converting enzyme in plasma concentrations of hydrogen sulfide and nitric oxide in patients with hypertension." | 3.81 | [Pharmacotherapy and analysis of gaseous mediators in hypertensive patients]. ( Balderrama, LP; Batalhão, ME; Carnio, EC; Eid, LP; Soriano, RN, 2015) |
| "Objective was to investigate the effects of Tai Chi exercise on nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S) levels, and blood pressure (BP) in patients with essential hypertension (EH)." | 3.81 | Effects of Tai Chi exercise on blood pressure and plasma levels of nitric oxide, carbon monoxide and hydrogen sulfide in real-world patients with essential hypertension. ( Pan, X; Tao, S; Zhang, Y, 2015) |
| " Hydrogen sulfide (H(2)S) is a prominent EDRF, since mice lacking its biosynthetic enzyme, cystathionine γ-lyase (CSE), display pronounced hypertension with deficient vasorelaxant responses to acetylcholine." | 3.77 | Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. ( Amzel, LM; Barodka, VM; Barrow, RK; Berkowitz, DE; Bhunia, AK; Gazi, FK; Gazi, SK; Jung, SM; Mustafa, AK; Sikka, G; Snyder, SH; Steppan, J; Wang, R, 2011) |
| "Endogenous hydrogen sulfide (H(2)S) plays an important role in hypertension." | 3.77 | Erythrocytic or serum hydrogen sulfide association with hypertension development in untreated essential hypertension. ( Geng, B; Shi, XQ; Sun, NL; Tang, CS; Zeng, Q; Zhao, J; Zheng, M, 2011) |
| "To investigate the effects of hydrogen sulfide (H2S) on vascular inflammation and blood pressure in spontaneously hypertensive rats (SHR)." | 3.74 | [Hypotensive effects of hydrogen sulfide via attenuating vascular inflammation in spontaneously hypertensive rats]. ( DU, JB; Jin, HF; Liang, JM; Sun, Y; Tang, CS, 2008) |
| "Hyperhomocysteinemia and the novel signaling gasotransmitter H(2)S might play important roles in the pathogenesis and development of hypertension." | 3.74 | [Plasma hydrogen sulfide and homocysteine levels in hypertensive patients with different blood pressure levels and complications]. ( Ma, Z; Sun, NL; Tang, CS; Xi, Y; Yang, SN, 2007) |
| "To explore the significance of hydrogen sulfide/cystathionine gamma-lyase (H(2)S/CSE) system in the development of hypertension and the effects of H(2)S/CSE system on the modulation of aortic remodeling process of hypertension." | 3.72 | [Changes and significance of hydrogen sulfide/cystathionine gamma-lyase system in hypertension: an experimental study with rats]. ( Du, JB; Tang, CS; Yan, H, 2004) |
| "Hypertension is the most common cause of cardiovascular morbidities and mortalities, and a major risk factor for renal dysfunction." | 2.55 | H ( Dugbartey, GJ, 2017) |
| "Hydrogen sulfide (H2S)has emerged as pivotal signaling molecules since it is recognized as the third gasotransmitter together with nitric oxide and carbon monoxide." | 2.55 | [The Molecular Switches and Atomic Biological Mechanisms Underlying the Physiological and Pathophysio-logical Effects of Hydrogen Sulfide to Regulate Its "Receptors"]. ( Cai, WJ; Li, XH; Tao, BB; Wang, MJ; Xue, WL; Zhu, YC, 2017) |
| "Hydrogen sulfide (H2S) is a gaseous signalling molecule with antihypertensive properties." | 2.53 | Hydrogen sulfide in hypertension. ( Hillebrands, JL; Joles, JA; van den Born, JC; van Goor, H, 2016) |
| " By having both direct effects on its receptor and increasing the bioavailability of vascular endothelial growth factor, H2S is proangiogenic." | 2.52 | Hydrogen sulfide: role in vascular physiology and pathology. ( Holwerda, KM; Karumanchi, SA; Lely, AT, 2015) |
| "Hydrogen sulfide (H2 S) has traditionally been viewed as a highly toxic gas; however, recent studies have implicated H2 S as a third member of the gasotransmitter family, exhibiting properties similar to NO and carbon monoxide." | 2.52 | Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. ( Ferro, A; Ji, Y; Ma, Y; Meng, G; Xie, L, 2015) |
| "The metabolic syndrome is a group of abnormalities including obesity, high blood pressure, hyperinsulinemia, high blood glucose levels and hyperlipidemia that together greatly increase the risk of developing cardiovascular disease and Type 2 diabetes." | 2.47 | Hydrogen sulfide and the metabolic syndrome. ( Chang, T; Desai, KM; Untereiner, A; Wu, L, 2011) |
| " Chronic administration of CSE inhibitor induces arterial hypertension in the rat." | 2.42 | [Hydrogen sulfide as a biologically active mediator in the cardiovascular system]. ( Bełtowski, J, 2004) |
| "Hypertension is a major risk factor for intimal hyperplasia (IH) and re-stenosis following vascular and endovascular interventions." | 1.72 | Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis. ( Allagnat, F; Corpataux, JM; Déglise, S; Deslarzes-Dubuis, C; Lambelet, M; Longchamp, A; Macabrey, D; Ozaki, CK, 2022) |
| "In newborns born to mothers with preeclampsia, an increase in the concentration of hydrogen sulfide was detected in the blood, which is probably a compensatory reaction aimed at restoring vascular homeostasis during early postnatal adaptation." | 1.62 | Hydrogen sulfide content in pregnant women with preeclampsia in late gestation and their newborns. ( Baev, TO; Kharlamova, NV; Klycheva, MM; Kuzmenko, GN; Nazarov, SB; Panova, IA; Popova, IG; Sadov, RI; Sitnikova, OG; Veselkova, YN, 2021) |
| "NaHS treatment decreased hypertension-induced Cx40/Cx43 expressions in T lymphocytes from SHR." | 1.48 | Hydrogen Sulfide Attenuates Hypertensive Inflammation via Regulating Connexin Expression in Spontaneously Hypertensive Rats. ( Li, L; Li, XZ; Ma, KT; Ni, X; Peng, M; Shan, LY; Shen, TW; Si, JQ; Yu, XS; Zhang, L, 2018) |
| "Suramin treatment exerted negligible effect on the RAS pathway in the adult male offspring kidneys." | 1.43 | N-Acetylcysteine Prevents Programmed Hypertension in Male Rat Offspring Born to Suramin-Treated Mothers. ( Hsu, CN; Lee, CT; Lin, YJ; Tain, YL; Tsai, CC, 2016) |
| "Patients with sleep apnea and rodents exposed to intermittent hypoxia exhibit hypertension." | 1.43 | H2S production by reactive oxygen species in the carotid body triggers hypertension in a rodent model of sleep apnea. ( Khan, SA; Kumar, GK; Nanduri, J; Peng, YJ; Prabhakar, NR; Semenza, GL; Singh, A; Snyder, SH; Vasavda, C; Yuan, G, 2016) |
| "Hypertension is a risk factor for the cardiovascular diseases." | 1.42 | Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension. ( Akcali, KC; Ayaloglu-Butun, F; Demirel-Yilmaz, E; Han, S; Uludag, MO; Usanmaz, SE, 2015) |
| " Both aortic endothelial function and NO bioavailability were significantly attenuated in the AngII group (P < 0." | 1.42 | Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice. ( Al-Magableh, MR; Hart, JL; Kemp-Harper, BK, 2015) |
| "Hydrogen sulfide (H2S) is an endogenously produced gasotransmitter with cardioprotective properties." | 1.42 | Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats. ( de Boer, RA; Frenay, AR; Hillebrands, JL; Leuvenink, HG; Pasch, A; Snijder, PM; van Goor, H, 2015) |
| " H2S therapy can also restore eNOS function and NO bioavailability and attenuate the pathological changes in the liver in L-NAME-induced hypertensive rats." | 1.40 | Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway. ( Dai, J; Duan, X; Ji, W; Jiang, X; Liu, S; Wu, Y; Yang, T, 2014) |
| "Hydrogen sulfide is a vasorelaxant and proangiogenic gas with therapeutic potential in several diseases." | 1.40 | Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor. ( Burke, SD; Faas, MM; Holwerda, KM; Jaffe, IZ; Kang, PM; Karumanchi, SA; Lely, AT; McCurley, A; Stillman, IE; van Goor, H; Zsengeller, Z, 2014) |
| "The exact etiology of preeclampsia is unknown, but there is growing evidence of an imbalance in angiogenic growth factors and abnormal placentation." | 1.39 | Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. ( Ahmad, S; Ahmed, A; Baily, J; Buhimschi, CS; Buhimschi, IA; Cai, M; Crispi, F; Cudmore, M; Fujisawa, T; Gratacós, E; Hadoke, PW; Miller, MR; Rennie, J; Wang, K; Wang, R, 2013) |
| "Hydrogen sulfide (H(2)S) is a poisonous gas which can be lethal." | 1.37 | Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: how harmful is it? ( Capasso, R; De Santo, NG; Ingrosso, D; Lanza, D; Perna, AF; Raiola, I; Sepe, I, 2011) |
| "Hypertension is the leading cause of cardiovascular diseases, and an estimated 972 million people in the world are suffering from this problem." | 1.35 | Calcium sulfide (CaS), a donor of hydrogen sulfide (H(2)S): a new antihypertensive drug? ( Hui, RT; Li, YF; Xiao, CS, 2009) |
| "Hypertension is a common disease of the cardiovascular system." | 1.34 | Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. ( Chen, L; Ding, YG; DU, JB; Ingrid, S; Liu, Y; Qi, JG; Tang, CS, 2007) |
| "Hydrogen sulfide (H(2)S) is a newly found modulator in vascular system." | 1.32 | The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. ( Du, J; Tang, C; Yan, H, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.52) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 20 (16.81) | 29.6817 |
| 2010's | 77 (64.71) | 24.3611 |
| 2020's | 19 (15.97) | 2.80 |
| Authors | Studies |
|---|---|
| Macabrey, D | 1 |
| Deslarzes-Dubuis, C | 1 |
| Longchamp, A | 1 |
| Lambelet, M | 1 |
| Ozaki, CK | 1 |
| Corpataux, JM | 1 |
| Allagnat, F | 1 |
| Déglise, S | 1 |
| Piragine, E | 2 |
| Citi, V | 2 |
| Lawson, K | 1 |
| Calderone, V | 3 |
| Martelli, A | 3 |
| Wu, H | 1 |
| Li, X | 3 |
| He, C | 1 |
| Liu, Y | 2 |
| Wang, C | 1 |
| Yang, X | 1 |
| Ma, F | 1 |
| Liu, J | 4 |
| Xu, J | 2 |
| Zhu, C | 1 |
| Liu, Q | 1 |
| Wei, R | 1 |
| Ge, T | 1 |
| Zheng, X | 1 |
| Li, B | 1 |
| Liu, K | 1 |
| Cui, R | 1 |
| Ranjbar, T | 3 |
| Oza, PP | 3 |
| Kashfi, K | 3 |
| Bełtowski, J | 5 |
| Kowalczyk-Bołtuć, J | 2 |
| Xia, WJ | 1 |
| Liu, KL | 1 |
| Wang, XM | 1 |
| Yang, Y | 1 |
| Meng, T | 1 |
| Qiao, JA | 1 |
| Zhang, N | 1 |
| Sun, YJ | 1 |
| Kang, YM | 1 |
| Yu, XJ | 1 |
| Wang, R | 6 |
| Malanima, MA | 1 |
| Lucenteforte, E | 1 |
| Cacanyiova, S | 3 |
| Majzunova, M | 1 |
| Golas, S | 1 |
| Berenyiova, A | 3 |
| Shi, MM | 1 |
| Wang, JL | 1 |
| Zhang, LQ | 1 |
| Qin, M | 1 |
| Huang, YW | 1 |
| Donertas Ayaz, B | 1 |
| Zubcevic, J | 1 |
| Kang, SC | 1 |
| Sohn, EH | 1 |
| Lee, SR | 1 |
| Chi, Z | 2 |
| Le, TPH | 1 |
| Lee, SK | 1 |
| Guo, E | 1 |
| Kim, D | 1 |
| Lee, S | 1 |
| Seo, SY | 1 |
| Lee, SY | 3 |
| Kim, JH | 2 |
| Li, Y | 1 |
| Feng, Y | 1 |
| Liu, L | 1 |
| Li, XY | 1 |
| Sun, X | 2 |
| Li, KX | 1 |
| Zha, RR | 1 |
| Wang, HD | 1 |
| Zhang, MD | 1 |
| Fan, XX | 1 |
| Wu, D | 1 |
| Fan, Y | 1 |
| Zhang, HC | 1 |
| Qiao, GF | 1 |
| Li, BY | 1 |
| Zhu, ML | 1 |
| Zhao, FR | 1 |
| Zhu, TT | 1 |
| Wang, QQ | 1 |
| Wu, ZQ | 1 |
| Song, P | 1 |
| Wan, GR | 1 |
| Yin, YL | 1 |
| Li, P | 1 |
| Hsu, CN | 4 |
| Hou, CY | 1 |
| Chang-Chien, GP | 1 |
| Lin, S | 1 |
| Tain, YL | 5 |
| Kadekawa, K | 1 |
| Popova, IG | 1 |
| Sitnikova, OG | 1 |
| Nazarov, SB | 1 |
| Sadov, RI | 1 |
| Panova, IA | 1 |
| Baev, TO | 1 |
| Kuzmenko, GN | 1 |
| Kharlamova, NV | 1 |
| Klycheva, MM | 1 |
| Veselkova, YN | 1 |
| Jung, JK | 1 |
| Yoon, GE | 1 |
| Jang, G | 1 |
| Park, KM | 1 |
| Kim, I | 1 |
| Kim, JI | 1 |
| Chen, Y | 1 |
| Zeng, Q | 2 |
| Huang, X | 1 |
| Cai, J | 1 |
| Iciek, M | 1 |
| Kotańska, M | 1 |
| Knutelska, J | 1 |
| Bednarski, M | 1 |
| Zygmunt, M | 1 |
| Kowalczyk-Pachel, D | 1 |
| Bilska-Wilkosz, A | 1 |
| Górny, M | 1 |
| Sokołowska-Jeżewicz, M | 1 |
| Tomasova, L | 1 |
| Drapala, A | 2 |
| Jurkowska, H | 2 |
| Wróbel, M | 2 |
| Ufnal, M | 2 |
| Xiao, L | 3 |
| Dong, JH | 2 |
| Teng, X | 3 |
| Jin, S | 4 |
| Xue, HM | 3 |
| Liu, SY | 2 |
| Guo, Q | 4 |
| Shen, W | 1 |
| Ni, XC | 1 |
| Wu, YM | 3 |
| Cao, X | 1 |
| Wu, Z | 1 |
| Xiong, S | 1 |
| Cao, L | 1 |
| Sethi, G | 1 |
| Bian, JS | 2 |
| Sandu, RE | 1 |
| Dumbrava, D | 1 |
| Surugiu, R | 1 |
| Glavan, DG | 1 |
| Gresita, A | 1 |
| Petcu, EB | 1 |
| Chappell, MC | 1 |
| Ni, X | 1 |
| Zhang, L | 1 |
| Peng, M | 1 |
| Shen, TW | 1 |
| Yu, XS | 1 |
| Shan, LY | 1 |
| Li, L | 2 |
| Si, JQ | 1 |
| Li, XZ | 1 |
| Ma, KT | 1 |
| Seifi, B | 1 |
| Sajedizadeh, A | 1 |
| Kadkhodaee, M | 1 |
| Ranjbaran, M | 1 |
| Szijártó, IA | 1 |
| Markó, L | 1 |
| Filipovic, MR | 1 |
| Miljkovic, JL | 1 |
| Tabeling, C | 1 |
| Tsvetkov, D | 1 |
| Wang, N | 1 |
| Rabelo, LA | 1 |
| Witzenrath, M | 1 |
| Diedrich, A | 1 |
| Tank, J | 1 |
| Akahoshi, N | 1 |
| Kamata, S | 1 |
| Ishii, I | 1 |
| Gollasch, M | 1 |
| Xue, WL | 1 |
| Cai, WJ | 1 |
| Tao, BB | 1 |
| Wang, MJ | 1 |
| Li, XH | 1 |
| Zhu, YC | 1 |
| Li, J | 1 |
| Dong, J | 1 |
| Tian, D | 1 |
| Wu, Y | 2 |
| Byeon, HE | 1 |
| Seo, E | 1 |
| Nguyen, QT | 1 |
| Lee, W | 1 |
| Jeong, Y | 1 |
| Choi, J | 1 |
| Pandey, D | 1 |
| Berkowitz, DE | 2 |
| Zou, S | 1 |
| Shimizu, T | 1 |
| Yamamoto, M | 1 |
| Shimizu, S | 1 |
| Higashi, Y | 1 |
| Saito, M | 1 |
| Zochio, GP | 1 |
| Possomato-Vieira, JS | 1 |
| Chimini, JS | 1 |
| da Silva, MLS | 1 |
| Dias-Junior, CA | 1 |
| Bir, SC | 1 |
| Kevil, CG | 1 |
| Wang, K | 2 |
| Ahmad, S | 2 |
| Cai, M | 2 |
| Rennie, J | 2 |
| Fujisawa, T | 2 |
| Crispi, F | 2 |
| Baily, J | 2 |
| Miller, MR | 2 |
| Cudmore, M | 2 |
| Hadoke, PW | 2 |
| Gratacós, E | 2 |
| Buhimschi, IA | 2 |
| Buhimschi, CS | 2 |
| Ahmed, A | 2 |
| Holwerda, KM | 2 |
| Burke, SD | 1 |
| Faas, MM | 1 |
| Zsengeller, Z | 1 |
| Stillman, IE | 1 |
| Kang, PM | 1 |
| van Goor, H | 3 |
| McCurley, A | 1 |
| Jaffe, IZ | 1 |
| Karumanchi, SA | 2 |
| Lely, AT | 2 |
| Peng, YJ | 2 |
| Makarenko, VV | 1 |
| Nanduri, J | 2 |
| Vasavda, C | 2 |
| Raghuraman, G | 1 |
| Yuan, G | 2 |
| Gadalla, MM | 2 |
| Kumar, GK | 2 |
| Snyder, SH | 5 |
| Prabhakar, NR | 2 |
| Pan, X | 1 |
| Zhang, Y | 1 |
| Tao, S | 1 |
| Kaczor-Kamińska, M | 1 |
| Bronowicka-Adamska, P | 1 |
| Ahmad, FU | 2 |
| Sattar, MA | 2 |
| Rathore, HA | 2 |
| Tan, YC | 1 |
| Akhtar, S | 1 |
| Jin, OH | 1 |
| Pei, YP | 1 |
| Abdullah, NA | 2 |
| Johns, EJ | 2 |
| Zhu, XB | 1 |
| Jiang, J | 1 |
| Jiang, R | 1 |
| Chen, F | 2 |
| Wesseling, S | 1 |
| Fledderus, JO | 1 |
| Verhaar, MC | 1 |
| Joles, JA | 2 |
| Tsikas, D | 1 |
| Cooper, AJ | 1 |
| Snijder, PM | 1 |
| Frenay, AR | 1 |
| de Boer, RA | 1 |
| Pasch, A | 1 |
| Hillebrands, JL | 2 |
| Leuvenink, HG | 1 |
| Al-Magableh, MR | 1 |
| Kemp-Harper, BK | 1 |
| Hart, JL | 1 |
| Sikora, M | 1 |
| Meng, G | 1 |
| Ma, Y | 1 |
| Xie, L | 1 |
| Ferro, A | 1 |
| Ji, Y | 1 |
| Sun, L | 2 |
| Jin, H | 3 |
| Chen, S | 3 |
| Huang, Y | 3 |
| Li, Z | 1 |
| Zhao, M | 1 |
| Sun, Y | 3 |
| Tang, C | 6 |
| Zhao, B | 1 |
| Du, J | 6 |
| Han, S | 1 |
| Uludag, MO | 1 |
| Usanmaz, SE | 1 |
| Ayaloglu-Butun, F | 1 |
| Akcali, KC | 1 |
| Demirel-Yilmaz, E | 1 |
| Wolin, MS | 1 |
| Stubbert, D | 1 |
| Prysyazhna, O | 1 |
| Rudyk, O | 1 |
| Scotcher, J | 1 |
| Burgoyne, JR | 1 |
| Eaton, P | 1 |
| Ji, W | 1 |
| Liu, S | 1 |
| Dai, J | 1 |
| Yang, T | 1 |
| Jiang, X | 1 |
| Duan, X | 1 |
| Zhang, R | 1 |
| Chen, Q | 1 |
| Chen, J | 1 |
| Zong, Y | 1 |
| Feng, S | 1 |
| Liu, AD | 1 |
| Holmberg, L | 1 |
| Liu, D | 1 |
| d'Emmanuele di Villa Bianca, R | 1 |
| Mitidieri, E | 1 |
| Donnarumma, E | 1 |
| Tramontano, T | 1 |
| Brancaleone, V | 1 |
| Cirino, G | 2 |
| Bucci, M | 1 |
| Sorrentino, R | 1 |
| Li, H | 3 |
| Feng, SJ | 1 |
| Zhang, GZ | 1 |
| Wang, SX | 1 |
| Huang, P | 1 |
| Wang, Y | 1 |
| Yao, Q | 1 |
| Zhu, M | 1 |
| Wang, S | 1 |
| Tao, Y | 1 |
| Yang, G | 2 |
| Duan, XC | 1 |
| Guo, R | 1 |
| Eid, LP | 1 |
| Soriano, RN | 1 |
| Batalhão, ME | 1 |
| Balderrama, LP | 1 |
| Carnio, EC | 1 |
| Testai, L | 1 |
| D'Antongiovanni, V | 1 |
| Piano, I | 1 |
| Duranti, E | 1 |
| Virdis, A | 1 |
| Blandizzi, C | 1 |
| Gargini, C | 1 |
| Breschi, MC | 1 |
| Qu, Z | 1 |
| Zhang, J | 1 |
| Gao, W | 1 |
| Chen, H | 1 |
| Huang, H | 1 |
| Huo, L | 1 |
| Tai, IH | 1 |
| Sheen, JM | 1 |
| Lin, YJ | 2 |
| Yu, HR | 1 |
| Tiao, MM | 1 |
| Chen, CC | 1 |
| Huang, LT | 1 |
| van den Born, JC | 1 |
| Brampton, J | 1 |
| Aaronson, PI | 1 |
| Sabino, JP | 1 |
| Traslaviña, GA | 1 |
| Branco, LG | 1 |
| Lee, CT | 2 |
| Tsai, CC | 1 |
| Chan, JY | 1 |
| Khan, SA | 1 |
| Singh, A | 1 |
| Semenza, GL | 1 |
| Kristek, F | 2 |
| Drobna, M | 1 |
| Ondrias, K | 1 |
| Grman, M | 1 |
| Juman, S | 1 |
| Nara, Y | 1 |
| Yasui, N | 1 |
| Negishi, H | 1 |
| Okuda, H | 1 |
| Takado, N | 1 |
| Miki, T | 1 |
| Dugbartey, GJ | 1 |
| Wu, L | 2 |
| Jiang, B | 1 |
| Yang, W | 1 |
| Qi, J | 1 |
| Cao, K | 1 |
| Meng, Q | 1 |
| Mustafa, AK | 2 |
| Mu, W | 1 |
| Zhang, S | 1 |
| Zhao, X | 1 |
| Zhang, LK | 1 |
| Zhang, CY | 1 |
| Zeng, XJ | 1 |
| Yan, H | 6 |
| Jin, HF | 5 |
| Tang, CS | 11 |
| DU, JB | 10 |
| Liang, JM | 1 |
| Zoccali, C | 1 |
| Catalano, C | 1 |
| Rastelli, S | 1 |
| Li, YF | 1 |
| Xiao, CS | 1 |
| Hui, RT | 1 |
| Sanderson, K | 1 |
| Wang, XB | 1 |
| Wallace, JL | 1 |
| Caliendo, G | 1 |
| Santagada, V | 1 |
| Lu, M | 1 |
| Liu, YH | 1 |
| Goh, HS | 1 |
| Wang, JJ | 1 |
| Yong, QC | 1 |
| Sen, U | 1 |
| Mishra, PK | 1 |
| Tyagi, N | 1 |
| Tyagi, SC | 1 |
| Jamroz-Wiśniewska, A | 1 |
| Tokarzewska, D | 1 |
| Perna, AF | 2 |
| Luciano, MG | 1 |
| Ingrosso, D | 2 |
| Raiola, I | 2 |
| Pulzella, P | 1 |
| Sepe, I | 2 |
| Lanza, D | 2 |
| Violetti, E | 1 |
| Capasso, R | 2 |
| Lombardi, C | 1 |
| De Santo, NG | 2 |
| Gupta, YK | 1 |
| Dahiya, AK | 1 |
| Reeta, KH | 1 |
| Roy, A | 1 |
| Khan, AH | 1 |
| Islam, MT | 1 |
| Prieto, MC | 1 |
| Majid, DS | 1 |
| Sikka, G | 1 |
| Gazi, SK | 1 |
| Steppan, J | 1 |
| Jung, SM | 1 |
| Bhunia, AK | 1 |
| Barodka, VM | 1 |
| Gazi, FK | 1 |
| Barrow, RK | 1 |
| Amzel, LM | 1 |
| Desai, KM | 1 |
| Chang, T | 1 |
| Untereiner, A | 1 |
| Abdullah, MH | 1 |
| Tan, S | 1 |
| Yuzawa, Y | 1 |
| Zheng, M | 1 |
| Shi, XQ | 1 |
| Zhao, J | 1 |
| Sun, NL | 2 |
| Geng, B | 1 |
| Kotsiuba, AE | 1 |
| Chertok, VM | 1 |
| Wiliński, B | 1 |
| Wiliński, J | 1 |
| Somogyi, E | 1 |
| Gu, Q | 1 |
| Wang, B | 1 |
| Zhang, XF | 1 |
| Ma, YP | 1 |
| Liu, JD | 1 |
| Wang, XZ | 1 |
| KRAVCHENKO, AA | 1 |
| NEVRAEVA, AS | 1 |
| van Zwieten, PA | 1 |
| Zhong, G | 1 |
| Cheng, Y | 1 |
| Zunnunov, ZR | 1 |
| DANENKOV, II | 1 |
| Chen, L | 1 |
| Ingrid, S | 1 |
| Ding, YG | 1 |
| Qi, JG | 1 |
| Xi, Y | 1 |
| Yang, SN | 1 |
| Ma, Z | 1 |
| Popovich, AIa | 1 |
| Gavrilishina, GE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Dietary Supplementation Allicor on Patients With Multifocal Atherosclerosis After Peripheral Artery Revascularization Treatment During a Year[NCT05813171] | Phase 4 | 300 participants (Anticipated) | Interventional | 2023-04-20 | Not yet recruiting | ||
| The Effects of Dietary Supplementation Allicor on the Effectiveness of Treatment of Patients After Coronary Arteria Revascularization[NCT05803759] | Phase 4 | 200 participants (Anticipated) | Interventional | 2023-04-10 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
30 reviews available for hydrogen sulfide and Hypertension
| Article | Year |
|---|---|
Potential Effects of Natural H
Topics: Brassicaceae; Cardiovascular System; Garlic; Humans; Hydrogen Sulfide; Hypertension; Vasodilation | 2022 |
Potential Effects of Natural H
Topics: Brassicaceae; Cardiovascular System; Garlic; Humans; Hydrogen Sulfide; Hypertension; Vasodilation | 2022 |
Potential Effects of Natural H
Topics: Brassicaceae; Cardiovascular System; Garlic; Humans; Hydrogen Sulfide; Hypertension; Vasodilation | 2022 |
Potential Effects of Natural H
Topics: Brassicaceae; Cardiovascular System; Garlic; Humans; Hydrogen Sulfide; Hypertension; Vasodilation | 2022 |
Hydrogen sulfide: A new therapeutic target in vascular diseases.
Topics: Atherosclerosis; Humans; Hydrogen Sulfide; Hypertension; Inflammation; Signal Transduction | 2022 |
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.
Topics: Aged; COVID-19 Drug Treatment; Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Renin-Angiotens | 2022 |
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.
Topics: Aged; COVID-19 Drug Treatment; Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Renin-Angiotens | 2022 |
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.
Topics: Aged; COVID-19 Drug Treatment; Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Renin-Angiotens | 2022 |
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.
Topics: Aged; COVID-19 Drug Treatment; Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Renin-Angiotens | 2022 |
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.
Topics: Aged; COVID-19 Drug Treatment; Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Renin-Angiotens | 2022 |
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.
Topics: Aged; COVID-19 Drug Treatment; Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Renin-Angiotens | 2022 |
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.
Topics: Aged; COVID-19 Drug Treatment; Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Renin-Angiotens | 2022 |
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.
Topics: Aged; COVID-19 Drug Treatment; Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Renin-Angiotens | 2022 |
The Renin-Angiotensin-Aldosterone System, Nitric Oxide, and Hydrogen Sulfide at the Crossroads of Hypertension and COVID-19: Racial Disparities and Outcomes.
Topics: Aged; COVID-19 Drug Treatment; Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Renin-Angiotens | 2022 |
Hydrogen sulfide in the experimental models of arterial hypertension.
Topics: Animals; Antihypertensive Agents; Cystathionine gamma-Lyase; Hydrogen Sulfide; Hypertension; Male; M | 2023 |
Hydrogen sulfide in the experimental models of arterial hypertension.
Topics: Animals; Antihypertensive Agents; Cystathionine gamma-Lyase; Hydrogen Sulfide; Hypertension; Male; M | 2023 |
Hydrogen sulfide in the experimental models of arterial hypertension.
Topics: Animals; Antihypertensive Agents; Cystathionine gamma-Lyase; Hydrogen Sulfide; Hypertension; Male; M | 2023 |
Hydrogen sulfide in the experimental models of arterial hypertension.
Topics: Animals; Antihypertensive Agents; Cystathionine gamma-Lyase; Hydrogen Sulfide; Hypertension; Male; M | 2023 |
Roles of Hydrogen Sulfide in Hypertension Development and Its Complications: What, So What, Now What.
Topics: Animals; Cardiovascular System; Gasotransmitters; Humans; Hydrogen Sulfide; Hypertension; Signal Tra | 2023 |
Circulating Levels of Hydrogen Sulfide (H
Topics: Aged; Aging; Animals; Gasotransmitters; Humans; Hydrogen Sulfide; Hypertension; Kidney Diseases | 2023 |
Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide.
Topics: Animals; Brain; Dysbiosis; Gastrointestinal Microbiome; Humans; Hydrogen Sulfide; Hypertension; Infl | 2020 |
Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis.
Topics: Animals; Cardiomyopathies; Diabetes Mellitus; Fibrosis; Humans; Hydrogen Sulfide; Hypertension; Myoc | 2020 |
The role of hydrogen sulfide in cyclic nucleotide signaling.
Topics: Animals; Cardiovascular Diseases; Gasotransmitters; Humans; Hydrogen Sulfide; Hypertension; Nucleoti | 2018 |
Cellular and Molecular Mechanisms Underlying Non-Pharmaceutical Ischemic Stroke Therapy in Aged Subjects.
Topics: Animals; Brain Ischemia; Caloric Restriction; Comorbidity; Diabetes Mellitus; Diet, High-Fat; Diseas | 2017 |
Hydrogen Sulfide in Hypertension and Kidney Disease of Developmental Origins.
Topics: Animals; Antihypertensive Agents; Epigenesis, Genetic; Gene Expression Regulation; Humans; Hydrogen | 2018 |
[The Molecular Switches and Atomic Biological Mechanisms Underlying the Physiological and Pathophysio-logical Effects of Hydrogen Sulfide to Regulate Its "Receptors"].
Topics: Asthma; Atherosclerosis; Carbon Monoxide; Cardiovascular System; Humans; Hydrogen Sulfide; Hypertens | 2017 |
[Cystathionine γ-lyase].
Topics: Animals; Cystathionine gamma-Lyase; Cysteine; Gene Expression; Glutathione; Humans; Hydrogen Sulfide | 2014 |
Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases.
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; China; Humans; Hydrogen Sulfide; Hyperten | 2015 |
Hydrogen sulfide: role in vascular physiology and pathology.
Topics: Animals; Female; Humans; Hydrogen Sulfide; Hypertension; Muscle, Smooth, Vascular; Myocytes, Smooth | 2015 |
Hydrogen sulfide in hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Humans; Hydrogen Sulfide; Hypertension; Thiosulfat | 2016 |
Role of Hydrogen Sulfide in Systemic and Pulmonary Hypertension: Cellular Mechanisms and Therapeutic Implications.
Topics: Animals; Humans; Hydrogen Sulfide; Hypertension; Hypertension, Pulmonary; Nitric Oxide; Potassium Ch | 2016 |
The role of hydrogen sulphide in blood pressure regulation.
Topics: Animals; Blood Pressure; Gasotransmitters; Hydrogen Sulfide; Hypertension; Mechanotransduction, Cell | 2016 |
H
Topics: Animals; Antihypertensive Agents; Humans; Hydrogen Sulfide; Hypertension; Kidney Diseases; Mice | 2017 |
[Role of gas signaling molecule hydrogen sulfide in cardiovascular diseases].
Topics: Animals; Cardiovascular Diseases; Coronary Disease; Humans; Hydrogen Sulfide; Hypertension; Hyperten | 2009 |
Hydrogen sulfide as a gasotransmitter.
Topics: Animals; Blood Pressure; Carbon Monoxide; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; En | 2010 |
Homocysteine to hydrogen sulfide or hypertension.
Topics: Calcium; Collagen; Homocysteine; Humans; Hydrogen Sulfide; Hyperhomocysteinemia; Hypertension; Muscl | 2010 |
Hydrogen sulfide, the third gaseous signaling molecule with cardiovascular properties, is decreased in hemodialysis patients.
Topics: Cardiovascular Diseases; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Humans; Hydrogen Su | 2010 |
Gaso-transmitter hydrogen sulphide: potential new target in pharmacotherapy.
Topics: Alzheimer Disease; Animals; Blood Pressure; Brain; Humans; Hydrogen Sulfide; Hypertension; Metabolic | 2010 |
Hydrogen sulfide and the metabolic syndrome.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hydrogen Sulfide; Hypertension; Metabolic | 2011 |
[Role of hydrogen sulfide in chronic kidney disease and diabetic nephropathy].
Topics: Animals; Chronic Disease; Diabetic Nephropathies; Humans; Hydrogen Sulfide; Hyperhomocysteinemia; Hy | 2012 |
Hypotensive effects of statins. A place for hydrogen sulfide in the puzzle?
Topics: Humans; Hydrogen Sulfide; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney | 2011 |
Hydrogen sulphide: not only foul smelling, but also pathophysiologically relevant.
Topics: Animals; Humans; Hydrogen Sulfide; Hypertension; Odorants | 2003 |
[Hydrogen sulfide as a biologically active mediator in the cardiovascular system].
Topics: Alzheimer Disease; Animals; Brain; Cardiovascular System; Cyclic AMP; Cystathionine beta-Synthase; D | 2004 |
[Significance of gaseous signal molecule in the pathogenesis of cardiovascular diseases].
Topics: Animals; Carbon Monoxide; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Hypertension; Hypertens | 2005 |
89 other studies available for hydrogen sulfide and Hypertension
| Article | Year |
|---|---|
Hydrogen Sulphide Release via the Angiotensin Converting Enzyme Inhibitor Zofenopril Prevents Intimal Hyperplasia in Human Vein Segments and in a Mouse Model of Carotid Artery Stenosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Carotid Arteries; Caro | 2022 |
Design, synthesis and biological evaluation of hydrogen sulfide-releasing isochroman-4-one derivatives as new antihypertensive agent candidates.
Topics: Antihypertensive Agents; Humans; Hydrogen Sulfide; Hypertension; Vasodilation | 2022 |
Hypothalamic Paraventricular Nucleus Hydrogen Sulfide Exerts Antihypertensive Effects in Spontaneously Hypertensive Rats via the Nrf2 Pathway.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Hydrogen Sulfide; Hyperten | 2023 |
The role of perivascular adipose tissue and endogenous hydrogen sulfide in vasoactive responses of isolated mesenteric arteries in normotensive and spontaneously hypertensive rats.
Topics: Adipose Tissue; Alkynes; Animals; Blood Pressure; Glycine; Hydrogen Sulfide; Hypertension; Male; Mes | 2019 |
Association between hydrogen sulfide and OSA-associated hypertension: a clinical study.
Topics: Adult; Aged; Association; Blood Pressure; Case-Control Studies; Continuous Positive Airway Pressure; | 2020 |
Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine γ-lyase degradation.
Topics: Acetylation; Angiotensin II; Animals; Aorta; Biphenyl Compounds; Cystathionine gamma-Lyase; Endothel | 2020 |
The baroreflex afferent pathway plays a critical role in H
Topics: Afferent Pathways; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Cardiotonic Agents; | 2021 |
The antihypertension effect of hydrogen sulfide (H
Topics: Animals; Antihypertensive Agents; Blood Pressure; Human Umbilical Vein Endothelial Cells; Humans; Hy | 2021 |
Maternal Garlic Oil Supplementation Prevents High-Fat Diet-Induced Hypertension in Adult Rat Offspring: Implications of H2S-Generating Pathway in the Gut and Kidneys.
Topics: Animals; Body Weight; Diet, High-Fat; Dietary Supplements; Fatty Acids, Volatile; Female; Garlic; Ga | 2021 |
Editorial Comment to Age-related differences in responses to hydrogen sulfide in the bladder of spontaneously hypertensive rats.
Topics: Animals; Hydrogen Sulfide; Hypertension; Rats; Rats, Inbred SHR; Urinary Bladder | 2021 |
Hydrogen sulfide content in pregnant women with preeclampsia in late gestation and their newborns.
Topics: Female; Humans; Hydrogen Sulfide; Hypertension; Infant, Newborn; Mothers; Pre-Eclampsia; Pregnancy; | 2021 |
Inhibition of HDACs (Histone Deacetylases) Ameliorates High-Fat Diet-Induced Hypertension Through Restoration of the MsrA (Methionine Sulfoxide Reductase A)/Hydrogen Sulfide Axis.
Topics: Animals; Diet, High-Fat; Histone Deacetylase Inhibitors; Histones; Hydrogen Sulfide; Hydroxamic Acid | 2021 |
Reduction of leukocyte-derived H
Topics: Adult; Aged; Blood Glucose; Cholesterol, HDL; Cystathionine gamma-Lyase; Down-Regulation; Female; Gl | 2017 |
The effect of NaCl on the level of reduced sulfur compounds in rat liver. Implications for blood pressure increase.
Topics: Animals; Cysteine; Free Radicals; Hydrogen Sulfide; Hypertension; Injections, Intraperitoneal; Injec | 2017 |
Na
Topics: Animals; Blood Pressure; Hydrogen Sulfide; Hypertension; Rats; Rats, Inbred SHR; Sulfides; Supposito | 2017 |
Hydrogen sulfide improves endothelial dysfunction in hypertension by activating peroxisome proliferator-activated receptor delta/endothelial nitric oxide synthase signaling.
Topics: Aged; AMP-Activated Protein Kinases; Animals; Arterial Pressure; Cystathionine gamma-Lyase; Endothel | 2018 |
Hydrogen sulfide, then nitric oxide and vasoprotection.
Topics: Humans; Hydrogen Sulfide; Hypertension; Nitric Oxide; Nitric Oxide Synthase Type III; PPAR delta | 2018 |
Hydrogen Sulfide Attenuates Hypertensive Inflammation via Regulating Connexin Expression in Spontaneously Hypertensive Rats.
Topics: Animals; Basilar Artery; Blood Pressure; Connexins; Hydrogen Sulfide; Hypertension; Inflammation; Ki | 2018 |
Long-term exercise restores hydrogen sulfide in the kidney and contributes to exercise benefits in 5/6 nephrectomized rats.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Hydrogen Sulfide; Hypertension; Kidney; Male; Malondialdeh | 2019 |
Cystathionine γ-Lyase-Produced Hydrogen Sulfide Controls Endothelial NO Bioavailability and Blood Pressure.
Topics: Animals; Biological Availability; Blood Pressure; Cystathionine gamma-Lyase; Disease Models, Animal; | 2018 |
Hydrogen sulfide improves endothelial dysfunction by inhibiting the vicious cycle of NLRP3 inflammasome and oxidative stress in spontaneously hypertensive rats.
Topics: Animals; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Sulfide; Hy | 2019 |
Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation.
Topics: Angiotensin II; Animals; Aorta; Cystathionine gamma-Lyase; Endothelial Cells; HEK293 Cells; Histone | 2019 |
Hydrogen sulfide-induced relaxation of the bladder is attenuated in spontaneously hypertensive rats.
Topics: Animals; Hydrogen Sulfide; Hypertension; Male; Muscle Relaxation; Rats, Inbred SHR; Rats, Wistar; Ur | 2019 |
Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Female; Fetal Growth Retardation; Fetus; Hydrogen | 2019 |
Sulfane sustains vascular health: insights into cystathionine γ-lyase function.
Topics: Animals; Atherosclerosis; Cystathionine gamma-Lyase; Female; Humans; Hydrogen Sulfide; Hypertension; | 2013 |
Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
Topics: Adolescent; Adult; Alkynes; Animals; Antigens, CD; Cells, Cultured; Cystathionine gamma-Lyase; Disea | 2013 |
Hydrogen sulfide attenuates sFlt1-induced hypertension and renal damage by upregulating vascular endothelial growth factor.
Topics: Animals; Female; Hydrogen Sulfide; Hypertension; Kidney Glomerulus; Podocytes; Proteinuria; Rats; Ra | 2014 |
Inherent variations in CO-H2S-mediated carotid body O2 sensing mediate hypertension and pulmonary edema.
Topics: Animals; Body Weight; Carbon Monoxide; Carotid Body; Catecholamines; Cystathionine gamma-Lyase; Heme | 2014 |
Effects of Tai Chi exercise on blood pressure and plasma levels of nitric oxide, carbon monoxide and hydrogen sulfide in real-world patients with essential hypertension.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Blood Pressure Determination; Carbon Monoxide; Essential | 2015 |
Hydrogen sulphide and tempol treatments improve the blood pressure and renal excretory responses in spontaneously hypertensive rats.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Cyclic N-Oxides; Disease Models, Animal; Drinkin | 2014 |
[Expressions of CSE and CBS in the corpus cavernosum of spontaneous hypertensive rats].
Topics: Animals; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Gene Expression Regulation; Hydroge | 2014 |
Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal.
Topics: Alkynes; Animals; Carbon Monoxide; Cystathionine gamma-Lyase; Glycine; Heme Oxygenase-1; Hydrogen Su | 2015 |
Letter by Tsikas and Cooper regarding article, "dysregulation of hydrogen sulfide (H2S) producing enzyme cystathionine γ-lyase (CSE) contributes to maternal hypertension and placental abnormalities in preeclampsia".
Topics: Animals; Cystathionine gamma-Lyase; Female; Humans; Hydrogen Sulfide; Hypertension; Placenta Disease | 2014 |
Response to letter regarding article, "dysregulation of hydrogen sulfide (H2S) producing enzyme cystathionine γ-lyase (CSE) contributes to maternal hypertension and placental abnormalities in preeclampsia".
Topics: Animals; Cystathionine gamma-Lyase; Female; Humans; Hydrogen Sulfide; Hypertension; Placenta Disease | 2014 |
Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Disease Models, Anim | 2015 |
Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cystathionine gamma-Lyase; Disease Models, Animal; Drug Eva | 2015 |
Exogenous hydrogen sulfide causes different hemodynamic effects in normotensive and hypertensive rats via neurogenic mechanisms.
Topics: Angiotensin II; Animals; Blood Pressure; Brain; Heart Rate; Hydrogen Sulfide; Hypertension; Infusion | 2014 |
Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-β/Smad signaling pathway in spontaneously hypertensive rats.
Topics: Animals; Arterial Pressure; Cells, Cultured; Collagen Type I; Collagen Type III; Fibroblasts; Hydrog | 2015 |
Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension.
Topics: Animals; Antioxidants; Arginine; Biomarkers; Blood Pressure; Blood Vessels; Desoxycorticosterone Ace | 2015 |
Novel role for protein kinase g oxidative activation in the vasodilator and antihypertensive actions of hydrogen sulfide.
Topics: Animals; Blood Pressure; Cyclic GMP-Dependent Protein Kinase Type I; Hydrogen Sulfide; Hypertension; | 2014 |
Protein kinase G Iα oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide.
Topics: Animals; Blood Pressure; Cyclic GMP-Dependent Protein Kinase Type I; Disease Models, Animal; Hydroge | 2014 |
Hydrogen sulfide defends against the cardiovascular risk of Nw-nitro-L-argininemethyl ester-induced hypertension in rats via the nitric oxide/endothelial nitric oxide synthase pathway.
Topics: Animals; Cardiovascular Diseases; Hydrogen Sulfide; Hypertension; Liver; Male; NG-Nitroarginine Meth | 2014 |
Hydrogen sulfide upregulates KATP channel expression in vascular smooth muscle cells of spontaneously hypertensive rats.
Topics: Animals; Aorta; Blood Pressure; Cells, Cultured; Endothelin-1; Forkhead Box Protein O3; Forkhead Tra | 2015 |
Hydrogen sulfide is involved in dexamethasone-induced hypertension in rat.
Topics: Animals; Blood Pressure; Carotid Arteries; Dexamethasone; Hydrogen Sulfide; Hypertension; Male; Rats | 2015 |
Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy.
Topics: Adult; Aged; Carotid Artery Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Diabet | 2014 |
Down-regulated CBS/H2S pathway is involved in high-salt-induced hypertension in Dahl rats.
Topics: Animals; Blood Pressure; Hydrogen Sulfide; Hypertension; Kidney; Lyases; Male; Rats; Rats, Inbred Da | 2015 |
Cystathionine-β-Synthase Gene Transfer Into Rostral Ventrolateral Medulla Exacerbates Hypertension via Nitric Oxide in Spontaneously Hypertensive Rats.
Topics: Animals; Blood Pressure; Cystathionine beta-Synthase; Disease Models, Animal; Enzyme Induction; gamm | 2015 |
[Pharmacotherapy and analysis of gaseous mediators in hypertensive patients].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cross-S | 2015 |
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions.
Topics: Animals; Coronary Vessels; Hydrogen Sulfide; Hypertension; Male; Nitric Oxide; Nitroprusside; Rats; | 2015 |
Antihypertensive and cardioprotective effects of Cerebralcare granule® on spontaneously hypertensive rats from the perspective of the gaseous triumvirate NO-CO-H2S system.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Aorta, Thoracic; Drugs, Chinese Herbal; Hear | 2016 |
Maternal N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and prevents programmed hypertension in male offspring exposed to prenatal dexamethasone and postnatal high-fat diet.
Topics: Acetylcysteine; Animals; Dexamethasone; Diet, High-Fat; Female; Hydrogen Sulfide; Hypertension; Male | 2016 |
Role of central hydrogen sulfide on ventilatory and cardiovascular responses to hypoxia in spontaneous hypertensive rats.
Topics: Animals; Arterial Pressure; Cardiovascular Agents; Cardiovascular System; Disease Models, Animal; Fo | 2016 |
N-Acetylcysteine Prevents Programmed Hypertension in Male Rat Offspring Born to Suramin-Treated Mothers.
Topics: Acetylcysteine; Animals; Arginine; Blood Pressure; Female; Fetal Development; Hydrogen Sulfide; Hype | 2016 |
Maternal melatonin or N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and renal transcriptome to prevent prenatal N
Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Biomarkers; Female; Fetal Development; | 2016 |
H2S production by reactive oxygen species in the carotid body triggers hypertension in a rodent model of sleep apnea.
Topics: Animals; Carotid Body; Cystathionine gamma-Lyase; Disease Models, Animal; Heme Oxygenase (Decyclizin | 2016 |
Hydrogen Sulfide Improves Endothelial Dysfunction via Downregulating BMP4/COX-2 Pathway in Rats with Hypertension.
Topics: Animals; Blood Pressure; Bone Morphogenetic Protein 4; Cyclooxygenase 2; Down-Regulation; Endotheliu | 2016 |
The adaptive role of nitric oxide and hydrogen sulphide in vasoactive responses of thoracic aorta is triggered already in young spontaneously hypertensive rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Hydrogen Sulfide; Hypertension; In Vitro Techniques; Male; | 2016 |
Reduced Production of Hydrogen Sulfide and Sulfane Sulfur Due to Low Cystathionine β-Synthase Levels in Brain Astrocytes of Stroke-Prone Spontaneously Hypertensive Rats.
Topics: Animals; Astrocytes; Brain; Cell Survival; Cells, Cultured; Cystathionine beta-Synthase; Glucose Oxi | 2016 |
H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase.
Topics: Animals; Aorta; Blood Pressure; Calcium; Calmodulin; Cystathionine gamma-Lyase; Cysteine; Endotheliu | 2008 |
Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Cell Division; Collagen Type I; Hydrogen S | 2008 |
[Study on hydrogen sulfide as a gasotransmitter: from bench to bedside].
Topics: Animals; Apoptosis; Cell Proliferation; Diabetes Mellitus; Gases; Humans; Hydrogen Sulfide; Hyperten | 2008 |
[Hypotensive effects of hydrogen sulfide via attenuating vascular inflammation in spontaneously hypertensive rats].
Topics: Animals; Blood Pressure; Hydrogen Sulfide; Hypertension; I-kappa B Kinase; Inflammation; Intercellul | 2008 |
Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage.
Topics: Animals; Autocrine Communication; Blood Pressure; Cystathionine gamma-Lyase; Disease Models, Animal; | 2009 |
Calcium sulfide (CaS), a donor of hydrogen sulfide (H(2)S): a new antihypertensive drug?
Topics: Antihypertensive Agents; Calcium Compounds; Humans; Hydrogen Sulfide; Hypertension; Models, Cardiova | 2009 |
Physiology: Emissions control.
Topics: Animals; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Hypertension; Inflammation; Mice; Nitr | 2009 |
Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Blood Pressure; Cyclooxyg | 2010 |
Hydrogen sulfide inhibits plasma renin activity.
Topics: Adenylyl Cyclases; Animals; Blood Pressure; Cells, Cultured; Colforsin; Cyclic AMP; Disease Models, | 2010 |
Hypoxia in the renal medulla: implications for hydrogen sulfide signaling.
Topics: Animals; Humans; Hydrogen Sulfide; Hypertension; Hypoxia; Kidney; Kidney Medulla; Oxygen; Renal Insu | 2010 |
Hydrogen sulfide and its modulation in arterial hypertension and atherosclerosis.
Topics: Animals; Atherosclerosis; Blood Pressure; Body Fluids; Humans; Hydrogen Sulfide; Hypertension; Mice; | 2010 |
Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: how harmful is it?
Topics: Cardiovascular System; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Hypertension; Renal Dial | 2011 |
Interdependency of cystathione γ-lyase and cystathione β-synthase in hydrogen sulfide-induced blood pressure regulation in rats.
Topics: Alkynes; Aminooxyacetic Acid; Animals; Blood Pressure; Cystathionine beta-Synthase; Cystathionine ga | 2012 |
Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels.
Topics: Acetylcholine; Animals; Aorta; Cells, Cultured; Charybdotoxin; Cystathionine gamma-Lyase; Endotheliu | 2011 |
Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Diabetic Nephropathies; Disease Progression; Hydrogen Sulfide; Hypertension | 2012 |
Adequate hydrogen sulfide, healthy circulation.
Topics: Animals; Cardiovascular Diseases; Humans; Hydrogen Sulfide; Hypertension; Signal Transduction | 2011 |
Erythrocytic or serum hydrogen sulfide association with hypertension development in untreated essential hypertension.
Topics: Adolescent; Adult; Aged; Erythrocytes; Female; Humans; Hydrogen Sulfide; Hypertension; Male; Middle | 2011 |
[Immunohistochemical study of H(2)S-positive neurons in some brain structures of people with arterial hypertension].
Topics: Adolescent; Adult; Brain; Cystathionine beta-Synthase; Humans; Hydrogen Sulfide; Hypertension; Immun | 2012 |
Contribution of hydrogen sulfide and nitric oxide to exercise-induced attenuation of aortic remodeling and improvement of endothelial function in spontaneously hypertensive rats.
Topics: Animals; Aorta, Thoracic; Arginine; Blood Pressure; Endothelial Cells; Endothelium, Vascular; Exerci | 2013 |
[Endogenous H2S is involved in the development of spontaneous hypertension].
Topics: Animals; Aorta; Hydrogen Sulfide; Hypertension; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2003 |
[Autonomic labyrinthine reactions in patients with hypertension treated by inhalation of artificial hydrogen sulfide water (outside of a health resort)].
Topics: Administration, Inhalation; Autonomic Nervous System; Health Resorts; Humans; Hydrogen Sulfide; Hype | 1959 |
The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Cystathionine gamma-Lyase; Enzyme Inhibitors; Gene Express | 2003 |
[Clinical efficiency and tolerance of hydrogen sulfide balneotherapy in hypertensive patients living in arid zone].
Topics: Adult; Aged; Baths; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Desert Climate; Female; H | 2003 |
The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats.
Topics: Alkynes; Animals; Aorta, Thoracic; Blood Pressure; Cystathionine gamma-Lyase; Gene Expression Regula | 2004 |
[Treatment of hypertension with hydrogen sulfide baths].
Topics: Balneology; Baths; Blood Pressure; Blood Pressure Determination; Humans; Hydrogen Sulfide; Hypertens | 1951 |
[Changes of endogenous hydrogen sulfide (H2S) in hypertensive rats].
Topics: Animals; Blood Pressure; Hydrogen Sulfide; Hypertension; Male; Random Allocation; Rats; Rats, Inbred | 2004 |
[Possible effects of endogenous hydrogen sulfide on aortic remodeling in hypertensive rats].
Topics: Animals; Aorta, Thoracic; Blood Pressure; Hydrogen Sulfide; Hypertension; Male; Rats; Rats, Inbred S | 2004 |
[Changes and significance of hydrogen sulfide/cystathionine gamma-lyase system in hypertension: an experimental study with rats].
Topics: Animals; Aorta, Thoracic; Cystathionine gamma-Lyase; Hydrogen Sulfide; Hypertension; Male; Random Al | 2004 |
Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children.
Topics: Adolescent; Child; Female; Homocysteine; Humans; Hydrogen Sulfide; Hypertension; Male; Systole | 2007 |
[Plasma hydrogen sulfide and homocysteine levels in hypertensive patients with different blood pressure levels and complications].
Topics: Adult; Aged; Blood Pressure; Case-Control Studies; Female; Gases; Homocysteine; Humans; Hydrogen Sul | 2007 |
[Use of hydrogen sulfide baths from Konopkivka spring in the overall treatment of hypertension].
Topics: Adult; Baths; Chronic Disease; Evaluation Studies as Topic; Humans; Hydrogen Sulfide; Hypertension; | 1979 |